Lantern Pharma (LTRN) Tops Q1 EPS by 12c

Lantern Pharma (NASDAQ: LTRN) reported Q1 EPS of ($0.36), $0.12 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• BMO Capital Reiterates Market Perform Rating on Axalta Coating Systems (AXTA)
• DA Davidson Reiterates Buy Rating on Vulcan Materials Company (VMC)